Wockhardt Limited
WOCKPHARMA
Kedudukan dalam Saham
#4493
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Harga Saham
$21.04
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$3.42B
Perubahan (1 hari)
-2.39%
Perubahan (1 tahun)
38.07%
Negara
IN
Perdagangan Wockhardt Limited (WOCKPHARMA)
Kategori
Healthcare
Sejarah hasil dividen untuk Wockhardt Limited (WOCKPHARMA)
Hasil dividen (TTM) bagi Wockhardt Limited (simbol saham: WOCKPHARMA) pada 2024-03-31 adalah: 0.00%
Purata hasil dividen 5 tahun terakhir: 0.01%
Purata hasil dividen 5 tahun terakhir: 0.01%
Sejarah hasil dividen untuk Wockhardt Limited (WOCKPHARMA) dari 2004 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 0.06% | 500.00% |
| 2021 | 0.01% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 1.60% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 1.10% | -63.46% |
| 2014 | 3.01% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | 0.01% | -99.60% |
| 2008 | 2.49% | -28.86% |
| 2007 | 3.50% | 136.49% |
| 2006 | 1.48% | 26.50% |
| 2005 | 1.17% | 60.27% |
| 2004 | 0.73% | 0.00% |
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
| Syarikat | Hasil Dividen | Negara |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
